Moderna vaccine shows 94.1% efficacy in trial: Study

Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's Covid-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3n334dk
via

Comments

Popular posts from this blog

'Lying Liz'? Did Donald Trump call for Liz Cheney's execution? Here's the truth

New Jersey man pleads guilty to murdering and dismembering two women: Faces 40 years in prison